IL-13Rα2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1103-1109

  Rahaman, Shaik Ohidar ^a   Sharma, Pankaj ^a,a   Harbor, Phyllis C ^a   Vogelbaum, Michael A ^a,a   Haque, S Jaharul ^a   Aman, M Javad ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b US Army Medical Institute of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; MEMBRANE PROTEIN; RECEPTOR SUBUNIT; STAT6 PROTEIN;

ARTICLE; ASTROCYTE; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GLIOBLASTOMA; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENE;

3T3 CELLS; ANIMALS; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-4; MICE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0036168305     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Interleukin-4: A prototypic immunoregulatory lymphokine
2. IL-4 and IL-13 receptors: Are they one and the same?
3. The IL-4 receptor: Signaling mechanisms and biologic functions
4. IL-4 and IL-13 signaling beyond JAK/STAT
5. Jaks and STATs: Biological implications
6. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits
7. JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes
8. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15
9. cDNA cloning and characterization of the human interleukin 13 receptor α chain
10. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
11. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4
12. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1
13. Active and inactive protein kinases: Structural basis for regulation
14. An interleukin-4-induced transcription factor
15. Components of a Stat recognition code: Evidence for two layers of molecular selectivity
16. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6
17. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
18. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction
19. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling
20. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain
21. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor α-chains
22. The murine IL-13 receptor α 2: Molecular cloning, characterization, and comparison with murine IL-13 receptor α I
23. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: Overexpression of the nonsignaling interleukin-13 receptor α2
24. Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells
25. Interleukin-13 receptor a chain: A novel tumor-associated transmembrane protein in primary explants of human malignant gliomas
26. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: Non-neoplastic glia and low-grade astrocytoma differ from malignant glioma
27. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation
28. Receptor for interleukin (IL)-13 does not interact with IL-4 but receptor for IL-4 interacts with IL-13 on human glioma cells
29. Interleukin-13 receptor α′ but not α chain: A functional component of interleukin-4 receptors
30. Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation
31. Human astrocyte growth regulation: Interleukin-4 sensitivity and receptor expression
32. The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation
33. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion
34. Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi’s sarcoma tumors in xenograft model
35. Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma
36. Molecular aspects of neuro-oncology
37. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity
38. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily
39. Roles of protein-tyrosine phosphatases in Stat1 α-mediated cell signaling
40. A protein tyrosine kinase in the interferon α/β signaling pathway
41. Signal transduction in the interferon system
42. How cells respond to interferons
43. Cytokine signaling: Cytokine-inducible signaling inhihitors
44. Negative regulation of the JAK/STAT pathway
45. Negative regulation of cytokine signaling pathways
46. Soluble cytokine receptors
47. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy
48. Structure and function of interleukin-4 and its receptor
49. Identification of a T cell-derived B cell growth factor distinct from interleukin 2
50. Proteasome-dependent degradation of p27/kip1 in gliomas
51. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4
52. Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme
53. Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin
54. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene
55. IL-4 gene transfer for the treatment of experimental gliomas
56. Gene therapy of experimental brain tumors using neural progenitor cells
57. Role of medical history in brain tumour development. Results from the international adult brain tumour study
58. Induction and regulation of the IgE response
59. The epidemic of allery and asthma